SERS-based nanobiosensing for ultrasensitive detection of the P53 tumor suppressor

International Journal of Nanomedicine

Volumn 6, Issue , 2011, Pages 2033-2042

  Domenici, Fabio ^a   Bizzarri, Anna Rita ^a   Cannistraro, Salvatore ^a  

^a UNIVERSITY OF TUSCIA   (Italy)

Author keywords

Atomic force microscopy; P53; Surface enhanced raman spectroscopy; Ultrasensitive detection

Indexed keywords

AZURIN; GOLD NANOPARTICLE; PROTEIN P53; 4 AMINOTHIOPHENOL; 4-AMINOTHIOPHENOL; ANILINE DERIVATIVE; BIOLOGICAL MARKER; DIAGNOSTIC AGENT; GOLD; METAL NANOPARTICLE; NANOCONJUGATE;

ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; NANOSENSOR; PARTICLE SIZE; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; RAMAN SPECTROMETRY; SENSITIVITY ANALYSIS; CHEMISTRY; GENETIC PROCEDURES; HUMAN; METHODOLOGY; SENSITIVITY AND SPECIFICITY;

ANILINE COMPOUNDS; AZURIN; BIOLOGICAL MARKERS; BIOSENSING TECHNIQUES; GOLD; HUMANS; METAL NANOPARTICLES; NANOCONJUGATES; PARTICLE SIZE; SENSITIVITY AND SPECIFICITY; SPECTRUM ANALYSIS, RAMAN; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84855877971     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S23845     Document Type: Article

References (57)

1. Stefanek ME, Andrykowski MA, Lerman C, Manne S, Glanz K. Behavioral oncology and the war on cancer: Partnering with biomedicine. Cancer Res. 2009;69:7151–7156.
2. Soper SA, Brown K, Ellington A, et al. Point-of-care biosensor systems for cancer diagnostics/prognostics. Biosens Bioelectron. 2006;21: 1932–1942.
3. Zusman I, Sandler B, Gurevich P, et al. Comparative study of the role of serum levels of p53 antigen and its tumor cell concentration in colon cancer detection. Hum Antibodies Hybridomas. 1996;7:123–128.
4. Shurbaji MS, Kalbfleisch JH, Thurmond TS. Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Hum Pathol. 1995;26:106–109.
5. Psyrri A, Kountourakis P, Yu Z, et al. Analysis of p53 protein expression levels on ovarian cancer tissue microarray using automated quantitative analysis elucidates prognostic patient subsets. Ann Oncol. 2007;18:709–715.
6. Malviya V, Singh H, Usha USD, Singh PB. Serum p53 and bladder cancer: Can serum p53 be used as a tumor marker? Urol Res. 2004;32: 391–394.
7. Shimada H, Nakajima K, Sakamoto K, et al. Existence of serum p53 antibodies in cyclosporine A-treated transplant patients: Possible detection of p53 protein over-expression. Transplant Proc. 2000;32:1779.
8. Portefaix JM, Fanutti C, Granier C, et al. Detection of anti-p53 antibodies by ELISA using p53 synthetic or phage-displayed peptides. J Immunol Methods. 2002;259:65–75.
9. Levesque MA, Katsaros D, Yu H, et al. Immunofluorometrically determined p53 accumulation as a prognostic indicator in Italian breast cancer patients. Int J Cancer. 1998;79:147–152.
10. Thomas MD, McIntosh GG, Anderson JJ, et al. A novel quantitative immunoassay system for p53 using antibodies selected for optimum designation of p53 status. J Clin Pathol. 1997;50:143–147.
11. Benini E, Costa A, Abolafio G, Silvestrini R. p53 Expression in human carcinomas: Could flow cytometry be an alternative to immunohistochemistry? J Histochem Cytochem. 1998;46:41–47.
12. Guihong Y, Da X, Shici T, Qun C. Rapid and sensitive immunomagneticelectrochemiluminescent detection of p53 antibodies in human serum. J Immunol Methods. 2004;288:47–54.
13. Cloarec JP, Chevolot Y, Laurenceau E, Phaner-Goutorbe M, Souteyrand E. A multidisciplinary approach for molecular diagnostics based on biosensors and microarrays. IRBM. 2008;29:105–127.
14. Chung JW, Kim SD, Bernhardt R, Pyun JC. Application of SPR biosensor for medical diagnostics of human hepatitis B virus (hHBV). Sensors and Actuators B. 2005;111–112:416–422.
15. Chen H, Jiang C, Yu C, Zhang S, Liu B, Kong J. Protein chips and nanomaterials for application in tumor marker immunoassays. Biosens Bioelectron. 2009;24:3399–3411.
16. Yeo J, Park JY, Bae WJ, et al. Label-free electrochemical detection of the p53 core domain protein on its antibody immobilized electrode. Anal Chem. 2009;81:4770–4777.
17. El-Sayed IH, Huang X, El-Sayed MA. Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: Applications in oral cancer. Nano Lett. 2005;5:829–834.
18. Boisselier E, Astruc D. Gold nanoparticles in nanomedicine: Preparations, imaging, diagnostics, therapies and toxicity. Chem Soc Rev. 2009;38:1759–1782.
19. Campion A, Kambhampati P. Surface enhanced Raman scattering. Chem Soc Rev. 1998;127:241–250.
20. Wei A, Kim B, Sadtler B, Tripp SL. Tunable surface-enhanced Raman scattering from large gold nanoparticles arrays. Chemphyschem. 2001; 12:743–745.
21. Kneipp K, Wang Y, Kneipp H, et al. Single molecule detection using surface enhanced Raman scattering. Phys Rev Lett. 1996;70:1667–1670.
22. Nie S, Emory SR. Probing single molecules and single nanoparticles by surface-enhanced Raman scattering. Science. 1997;275:1102–1106.
23. Bizzarri AR, Cannistraro S. Surface-enhanced Raman spectroscopy combined with atomic force microscopy for ultrasensitive detection of thrombin. Anal Biochem. 2009;393:149–154.
24. Bizzarri AR, Cannistraro S. SERS detection of thrombin by protein recognition using functionalized gold nanoparticles. Nanomedicine: Nanotechnology, Biology, and Medicine. 2007;3:306–310.
25. Bizzarri AR, Cannistraro S. Lévy statistics of vibrational mode fluctuations of single molecules from surface-enhanced Raman scattering. Phys Rev Lett. 2005;94:068303–068306.
26. Bizzarri AR, Cannistraro S. Statistical analysis of intensity fluctuations in single molecule SERS spectra. Phys Chem Chem Phys. 2009;9: 5314–5319.
27. Wang J, Kong LT, Guo Z, Xu JY, Liu JH. Synthesis of novel decorated one-dimensional gold nanoparticle and its application in ultrasensitive detection of insecticide. J Mater Chem. 2010;20:5271–5279.
28. Jackson JB, Halas NJ. Surface-enhanced Raman scattering on tunable plasmonic nanoparticle substrates. Proc Natl Acad Sci U S A. 2004;101:17930–17935.
29. Moskovits M. Surface-enhanced spectroscopy. Rev Mod Phys. 1985;57: 783–826.
30. Lombardi JR, Birke RL, Lu T, Xu J. Charge-transfer theory of surface enhanced Raman spectroscopy: Herzberg-Teller contributions. J Chem Phys. 1986;84:4174–4180.
31. Ru EC, Meyer M, Etchegoin PG. Proof of single-molecule sensitivity in surface enhanced Raman scattering (SERS) by means of a two-analyte technique. J Phys Chem B. 2006;110:1944–1948.
32. Yamada T, Goto M, Punj V, et al. Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer. Proc Natl Acad Sci U S A. 2002;99:14098–14103.
33. Yamada T, Hiraoka Y, Ikehata M, et al. Apoptosis or growth arrest: Modulation of tumor suppressor p53’s specificity by bacterial redox protein azurin. Proc Natl Acad Sci U S A. 2004;101:4770–4775.
34. Taranta M, Bizzarri AR, Cannistraro S. Probing the interaction between p53 and the bacterial protein azurin by single molecule force spectroscopy. J Mol Recognit. 2008;2:63–70.
35. De Grandis V, Bizzarri AR, Cannistraro S. Docking study and free energy simulation of the complex between p53 DNA-binding domain and azurin. J Mol Recognit. 2007;20:215–226.
36. Domenici F, Frasconi M, Mazzei F, D’Orazi G, Bizzarri AR, Cannistraro S. Azurin modulates the association of Mdm2 with p53: SPR evidence from interaction of the full-length proteins. J Mol Recognit. 2011;24:707–714.
37. Punj V, Das Gupta KT, Chakrabarty MA. Bacterial cupredoxin azurin and its interactions with the tumor suppression protein p53. Biochem Biophys Res Commun. 2003;312:109–114.
38. Adman ET. Copper protein structures. Adv Protein Chem. 1991;42: 145–197.
39. Guzzi R, Sportelli L. Interaction of azurin with alcohols: An ESR, optical absorption, and fluorescence emission investigation. J Inorg Biochem. 1992;45:39–45.
40. Funari G, Domenici F, Nardinocchi L, et al. Interaction of p53 with MDM2 and azurin as studied by atomic force spectroscopy. J Mol Recognit. 2009;23:343–351.
41. Morrison RT, Boyd RN. Organic Chemistry, 6th Edition. New Delhi. Prentice Hall; 1999.
42. Phillips JH, Robrish SA, Bates C. High efficiency coupling of diazonium ion to proteins and amino acids. J Biol Chem. 1965;240:699–704.
43. Park SH, Im JH, Chun BH, Kim JH. Adsorption kinetics of Au and Ag nanoparticles on functionalized glass surfaces. Microchem J. 1999;63:71–91.
44. Halliwell CM, Cass AEG. A factorial analysis of silanization conditions for the immobilization of oligonucleotides on glass surfaces. Anal Chem. 2001;73:2476–2483.
45. Baia M, Toderas F, Baia L, Popp J, Astilean S. Probing the enhancement mechanisms of SERS with p-aminothiophenol molecules adsorbed on self-assembled gold colloidal nanoparticles. Chem Phys Lett. 2006;422: 127–132.
46. Jiao LS, Niu L, Shen J, You T, Dong S, Ivaska A. Simple Azo derivation on 4-aminothiophenol/Au monolayer. Electrochem Commun. 2005;7:219–222.
47. Zhu Z, Zhu T, Liu Z. Raman scattering enhancement contributed from individual gold nanoparticles and interparticle coupling. Nanotechnology. 2004;15:357–364.
48. Osawa M, Matsuda N, Yoshii K, Uchida I. Charge transfer resonance raman process in surface-enhanced Raman scattering from p-aminothiophenol adsorbed on silver: Herzberg-Teller contribution. J Phys Chem. 1994;98:12702–12707.
49. Wu Y, Buranda T, Metzenberg RL, Sklar LA, Lopez G. Diazo coupling method for covalent attachment of proteins to solid substrates. Bioconjug Chem. 2006;17:359–365.
50. Andrikopoulos PC, McCarney KM, Armstrong DR, Littleford RE, Graham D, Smith WEA. Density functional theory and resonance Raman study of a benzotriazole dye used in surface enhanced resonance Raman scattering. J Mol Struct. 2006;789:59–70.
51. Sarah LW, Steven JO, Lee TR, Halas NJ. Construction of simple gold nanoparticle aggregates with controlled plasmon-plasmon interactions. Chem Phys Lett. 1999;300:651–655.
52. Wang Y, Zhu X, Wu M, Xia N, Wang J, Zhou F. Simultaneous and label-free determination of wild-type and mutant p53 at a single surface plasmon resonance chip preimmobilized with consensus DNA and monoclonal antibody. Anal Chem. 2009;81:8441–8446.
53. Jia CP, Zhong XQ, Hua B, et al. Nano-ELISA for highly sensitive protein detection. Biosens Bioelectron. 2009;24:2836–2841.
54. Andolfi L, Bizzarri AR, Cannistraro S. Assembling of redox proteins on Au(111) surfaces: A scanning probe microscopy investigation for application in bio-nanodevices. Thin Solid Films. 2006;515:212–219.
55. Li J. Detection of ras p21 and p53 proteins in serum of the lung cancer patients exposed to indoor coal-burning pollution with Western blotting. Fuel and Energy Abstracts. 1997;38:350.
56. Hofseth LJ, Saito S, Hussain SP, et al. Nitric oxide-induced cellular stress and p53 activation in chronic inflammation. Proc Natl Acad Sci U S A. 2002;100:143–148.
57. Yang J, Duerksen-Hughes P. A new approach to identifying genotoxic carcinogens: p53 induction as an indicator of genotoxic damage. Carcinogenesis. 1998;19:1117–1125.